Should older adults be screened for dementia?

The question of whether to screen for dementia and Alzheimer's disease (AD) has been discussed in many forums throughout the world. Generally, medical advisory groups and policy‐making groups have recognized the importance of early diagnosis but have uniformly avoided making recommendations to screen at‐risk populations. This presentation reflects the support for reconsidering the importance of screening individuals at risk or above a certain age. In this statement, the majority of the authors support the consideration of dementia risk factors in individuals at age 50, with routine yearly screening after 75. Other authors remain concerned that the benefits of treatments of early disease do not yet support a general screening recommendation. These statements are made to encourage progress toward the development of a consensus regarding the widespread institution of screening policy. Accordingly, members of the worldwide scientific community are invited to add their perspective by contributing short commentaries (1500 words) on this subject.

[1]  H. Kraemer,et al.  Adjusting Mini-Mental State Examination Scores for Age and Educational Level to Screen for Dementia: Correcting Bias or Reducing Validity? , 1998, International Psychogeriatrics.

[2]  B. Reisberg,et al.  Mortality and Temporal Course of Probable Alzheimer's Disease: A 5-Year Prospective Study , 1996, International Psychogeriatrics.

[3]  S H Ferris,et al.  Neuropsychological Prediction of Decline to Dementia in Nondemented Elderly , 1999, Journal of geriatric psychiatry and neurology.

[4]  C. Patterson,et al.  The recognition, assessment and management of dementing disorders: conclusions from the Canadian Consensus Conference on Dementia. , 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[5]  H. Brodaty,et al.  The GPCOG: A New Screening Test for Dementia Designed for General Practice , 2002, Journal of the American Geriatrics Society.

[6]  R. Hills,et al.  AD2000: design and conclusions , 2004, The Lancet.

[7]  M. Albert,et al.  Early identification of Alzheimer's disease and related dementias , 1997 .

[8]  P. Scheltens,et al.  Early diagnostic indices for the prevention of Alzheimer's disease. , 1998, Annals of medicine.

[9]  J. Cummings,et al.  Mild cognitive impairment (MCI) represents early-stage Alzheimer's disease. , 2005, Journal of Alzheimer's disease : JAD.

[10]  Mary Sano,et al.  Undertreatment of patients with Alzheimer’s disease in an elderly United States population , 2005, Alzheimer's & Dementia.

[11]  H. Kraemer,et al.  How can we learn about developmental processes from cross-sectional studies, or can we? , 2000, The American journal of psychiatry.

[12]  C. Clark,et al.  Earlier onset of Alzheimer disease symptoms in latino individuals compared with anglo individuals. , 2005, Archives of neurology.

[13]  Roberta F. White,et al.  The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort. , 2000, Archives of neurology.

[14]  R Brookmeyer,et al.  Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. , 1998, American journal of public health.

[15]  S. Balsis,et al.  Personality change precedes clinical diagnosis of dementia of the Alzheimer type. , 2005, The journals of gerontology. Series B, Psychological sciences and social sciences.

[16]  E. Larson Recognition of Dementia: Discovering the Silent Epidemic , 1998, Journal of the American Geriatrics Society.

[17]  J. Wesson Ashford,et al.  ApoE genotype accounts for the vast majority of AD risk and AD pathology , 2004, Neurobiology of Aging.

[18]  W. Tsai,et al.  A functional decline model for prevalent cohort data. , 1996, Statistics in medicine.

[19]  B. Reisberg,et al.  Mild cognitive impairment , 2005, The Lancet.

[20]  J. Ashford,et al.  Designing a Brief Alzheimer Screen (BAS). , 2003, Journal of Alzheimer's disease : JAD.

[21]  A. M. Clarfield,et al.  The decreasing prevalence of reversible dementias: an updated meta-analysis. , 2003, Archives of internal medicine.

[22]  W. Rocca Frequency, distribution, and risk factors for Alzheimer's disease. , 1994, The Nursing clinics of North America.

[23]  K. Beusterien,et al.  Impact of Rivastigmine Use on the Risk of Nursing Home Placement in a US Sample , 2004 .

[24]  C. Eisdorfer,et al.  Advances in the diagnosis and treatment of Alzheimer's disease , 1998 .

[25]  P. Passmore,et al.  AD2000: design and conclusions , 2004, The Lancet.

[26]  Susan Jaglal,et al.  Risk Factors for Harm in Cognitively Impaired Seniors Who Live Alone: A Prospective Study , 2004, Journal of the American Geriatrics Society.

[27]  P. Passmore,et al.  AD2000: design and conclusions. Authors' reply , 2004 .

[28]  L. Schneider,et al.  Long-term tacrine (Cognex) treatment , 1996, Neurology.

[29]  D. Jolley,et al.  Cost benefits of a medically supervised day treatment program for patients with Alzheimer's disease and other forms of dementia , 1989 .

[30]  K. Hall,et al.  The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis. , 1998, Archives of general psychiatry.

[31]  B. Winblad,et al.  Institutionalization in the elderly: the role of chronic diseases and dementia. Cross-sectional and longitudinal data from a population-based study. , 2001, Journal of clinical epidemiology.

[32]  J. Ashford,et al.  Diagnosis of Alzheimer ' s Disease , 1998 .

[33]  Z. Khachaturian,et al.  Screening for Cognitive Impairment in General Practice: Toward a Consensus , 1998, Alzheimer disease and associated disorders.

[34]  H. Buschke,et al.  Screening for Alzheimer's Disease: The Memory Impairment Screen Versus the Conventional Three‐Word Memory Test , 2002, Journal of the American Geriatrics Society.

[35]  J. Price,et al.  Mild cognitive impairment represents early-stage Alzheimer disease. , 2001, Archives of neurology.

[36]  B. Miller,et al.  CME Practice parameter : Diagnosis of dementia ( an evidence-based review ) Report of the Quality Standards Subcommittee of the American Academy of Neurology , 2001 .

[37]  Charles Hall,et al.  Modeling memory decline in older adults: the importance of preclinical dementia, attrition, and chronological age. , 2003, Psychology and aging.

[38]  J. Cummings,et al.  Guidelines for Managing Alzheimer's Disease , 2002 .

[39]  M. Albert,et al.  Application of a growth curve approach to modeling the progression of Alzheimer's disease. , 1996, The journals of gerontology. Series A, Biological sciences and medical sciences.

[40]  ANTEMORTEM MEMORY IMPAIRMENT SCREEN PERFORMANCE IS CORRELATED WITH POSTMORTEM ALZHEIMER PATHOLOGY , 2003, Journal of the American Geriatrics Society.

[41]  Alfred O. Berg,et al.  Screening for Depression: Recommendations and Rationale , 2002, Annals of Internal Medicine.

[42]  C. Jack,et al.  Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment , 2004, Journal of internal medicine.

[43]  R. Petersen Mild cognitive impairment as a diagnostic entity , 2004, Journal of internal medicine.

[44]  T. Tombaugh Test-retest reliable coefficients and 5-year change scores for the MMSE and 3MS. , 2005, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[45]  A. Rajasekar,et al.  Temporal quantification of Alzheimer's disease severity: 'time index' model. , 1995, Dementia.

[46]  Soo Borson,et al.  Simplifying Detection of Cognitive Impairment: Comparison of the Mini‐Cog and Mini‐Mental State Examination in a Multiethnic Sample , 2005, Journal of the American Geriatrics Society.

[47]  J P Miller,et al.  The AD8 , 2005, Neurology.

[48]  P. Aisen,et al.  One-trial 10-item free-recall performance in Taiwanese elderly and near-elderly: A potential screen for cognitive decline , 2005, American journal of Alzheimer's disease and other dementias.

[49]  J. Wesson Ashford,et al.  APOE genotype effects on alzheimer’s disease onset and epidemiology , 2007, Journal of Molecular Neuroscience.

[50]  B. Winblad,et al.  Clinical trials in mild cognitive impairment: lessons for the future , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[51]  R. Green,et al.  Screening for cognitive impairment in older individuals. Validation study of a computer-based test. , 1994, Archives of neurology.

[52]  H. Fillit,et al.  Health care utilization and costs of Alzheimer's disease: the role of co-morbid conditions, disease stage, and pharmacotherapy. , 2002, Family medicine.

[53]  J. Cummings,et al.  Evaluating dementia screening tests , 1999, Neurology.

[54]  The incidence of dementia in Canada. The Canadian Study of Health and Aging Working Group. , 2000, Neurology.

[55]  R Brookmeyer,et al.  Visual memory predicts Alzheimer’s disease more than a decade before diagnosis , 2003, Neurology.

[56]  R Brookmeyer,et al.  Age-specific incidence rates of Alzheimer’s disease , 2000, Neurology.

[57]  K. Shulman,et al.  IPA survey of brief cognitive screening instruments , 2006, International Psychogeriatrics.

[58]  D. Bennett,et al.  Vitamin E and donepezil for the treatment of mild cognitive impairment. , 2005, The New England journal of medicine.

[59]  Herman Buschke,et al.  Screening for Dementia by Telephone Using the Memory Impairment Screen , 2003, Journal of the American Geriatrics Society.

[60]  Peijun Chen,et al.  The Mini‐Cog as a Screen for Dementia: Validation in a Population‐Based Sample , 2003, Journal of the American Geriatrics Society.

[61]  D. Geldmacher,et al.  Donepezil Is Associated with Delayed Nursing Home Placement in Patients with Alzheimer's Disease , 2003, Journal of the American Geriatrics Society.

[62]  S. Borson,et al.  Improving identification of cognitive impairment in primary care , 2006, International journal of geriatric psychiatry.

[63]  J. Yesavage,et al.  Cognitive function and the costs of Alzheimer disease. An exploratory study. , 1997, Archives of neurology.

[64]  Christopher M. Callahan,et al.  Implementing a screening and diagnosis program for dementia in primary care , 2005, Journal of General Internal Medicine.

[65]  Lee Bowman,et al.  Impact of cognitive impairment on mild dementia patients and mild cognitive impairment patients and their informants , 2006, International Psychogeriatrics.

[66]  S. Borson,et al.  Brief Screening Tests for Dementia , 2002, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[67]  Howard Fillit,et al.  Economics of dementia and pharmacoeconomics of dementia therapy. , 2005, The American journal of geriatric pharmacotherapy.

[68]  Ruth O'Hara,et al.  Modeling the prevalence and incidence of Alzheimer's disease and mild cognitive impairment. , 2002, Journal of psychiatric research.

[69]  Screening for depression: recommendations and rationale. , 2002 .

[70]  Charles D. Smith,et al.  Neuropathologic substrate of mild cognitive impairment. , 2006, Archives of neurology.

[71]  Helena Chmura Kraemer,et al.  Categorical versus dimensional approaches to diagnosis: methodological challenges. , 2004, Journal of psychiatric research.

[72]  N. Relkin Screening and early diagnosis of dementia. , 2000, The American journal of managed care.

[73]  Bruno Dubois,et al.  Screening for Alzheimer’s Disease with the Short Cognitive Evaluation Battery , 2003, Dementia and Geriatric Cognitive Disorders.

[74]  D. Knopman,et al.  Prevalence, costs, and treatment of Alzheimer's disease and related dementia: a managed care perspective. , 2001, The American journal of managed care.

[75]  René Verreault,et al.  More Than the Epidemiology of Alzheimer's Disease: Contributions of the Canadian Study of Health and Aging , 2004, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[76]  V. Molinari,et al.  "Do-it-yourself" dementia testing: issues regarding an Alzheimer's home screening test. , 2003, The Gerontologist.

[77]  R. Hales,et al.  J Neuropsychiatry Clin Neurosci , 1992 .

[78]  A. Mackinnon,et al.  Combining cognitive testing and informant report to increase accuracy in screening for dementia. , 1998, The American journal of psychiatry.

[79]  P. Adlard,et al.  The cause of neuronal degeneration in Alzheimer's disease , 2000, Progress in Neurobiology.

[80]  William R. Shankle,et al.  Methods to improve the detection of mild cognitive impairment. , 2005 .

[81]  J. Ashford,et al.  Modeling the time-course of Alzheimer dementia , 2001, Current psychiatry reports.

[82]  N. Herrmann,et al.  Contribution of Informant and Patient Ratings to the Accuracy of the Mini‐Mental State Examination in Predicting Probable Alzheimer's Disease , 2003, Journal of the American Geriatrics Society.

[83]  Bruce L. Miller,et al.  Appendix B: Practice parameter: Diagnosis of dementia (an evidence-based review): Report of the quality standards subcommittee of the American academy neurology , 2007 .

[84]  B. Teter,et al.  Neuroplasticity in Alzheimer's disease , 2002, Journal of neuroscience research.

[85]  R. Brookmeyer,et al.  Methods for projecting the incidence and prevalence of chronic diseases in aging populations: application to Alzheimer's disease. , 2000, Statistics in medicine.

[86]  M. Kapp Should home screening tests for Alzheimer's disease be regulated? , 2003, The Gerontologist.

[87]  Kathleen N Lohr,et al.  Screening for Dementia in Primary Care: A Summary of the Evidence for the U.S. Preventive Services Task Force , 2003, Annals of Internal Medicine.

[88]        Global prevalence of dementia: a Delphi consensus study , 2006 .

[89]  J. Raftery,et al.  Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial , 2004, The Lancet.

[90]  David Haber,et al.  Guide to clinical preventive services: a challenge to physician resourcefulness , 1993 .

[91]  V. Valcour,et al.  The detection of dementia in the primary care setting. , 2000, Archives of internal medicine.

[92]  J. Ashford,et al.  “Preclinical” AD revisited , 2000, Neurology.

[93]  Nick Freemantle,et al.  North of England evidence based guidelines development project: guideline for the primary care management of dementia , 1998, BMJ.

[94]  L. Frank,et al.  Assessing functioning and self-care abilities in Alzheimer disease research. , 1997, Alzheimer disease and associated disorders.

[95]  J. Cummings,et al.  Cognitive screening instruments in neuropsychiatry: a report of the Committee on Research of the American Neuropsychiatric Association. , 1997, The Journal of neuropsychiatry and clinical neurosciences.

[96]  Vijaya L. Melnick,et al.  Alzheimer’s Dementia , 1985, Contemporary Issues in Biomedicine, Ethics, and Society.

[97]  Jill Manthorpe,et al.  Sooner or later? Issues in the early diagnosis of dementia in general practice: a qualitative study. , 2003, Family practice.

[98]  Anthony F Jorm The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): a review , 2004, International Psychogeriatrics.

[99]  R. Mayeux,et al.  Primary care expenditures before the onset of Alzheimer’s disease , 2002, Neurology.

[100]  Brian Mittman,et al.  Guidelines for managing Alzheimer's disease: part I. Assessment. , 2002, American family physician.

[101]  J. Morris,et al.  Predictors of preclinical Alzheimer disease and dementia: a clinicopathologic study. , 2005, Archives of neurology.

[102]  G. Schellenberg,et al.  Dementia and Alzheimer disease incidence: a prospective cohort study. , 2002, Archives of neurology.

[103]  W F Stewart,et al.  Screening for dementia with the Memory Impairment Screen , 1999, Neurology.

[104]  J. Last,et al.  Making the Dictionary of Epidemiology. , 1996, International journal of epidemiology.

[105]  H. Fillit,et al.  Donepezil use in managed Medicare: effect on health care costs and utilization. , 1999, Clinical therapeutics.

[106]  E. R. John,et al.  Prediction of longitudinal cognitive decline in normal elderly with subjective complaints using electrophysiological imaging , 2006, Neurobiology of Aging.

[107]  C B Hall,et al.  Estimation of bivariate measurements having different change points, with application to cognitive ageing , 2001, Statistics in medicine.

[108]  S. Borson,et al.  The Mini‐Cog: a cognitive ‘vital signs’ measure for dementia screening in multi‐lingual elderly , 2000, International journal of geriatric psychiatry.

[109]  L. Matza,et al.  Validation of a new symptom impact questionnaire for mild to moderate cognitive impairment , 2006, International Psychogeriatrics.

[110]  Zaven S. Khachaturian,et al.  Diagnosis of Alzheimer’s disease: Two decades of progress* , 2005, Alzheimer's & Dementia.

[111]  R. Friedland Strategies for Driving Cessation in Alzheimer Disease , 1997, Alzheimer disease and associated disorders.

[112]  James C Mundt,et al.  A Novel Interactive Voice Response (IVR) System for Dementia Screening, Education, and Referral: One-Year Summary , 2005, Alzheimer disease and associated disorders.

[113]  J. Ashford,et al.  Severe family violence and Alzheimer's disease: prevalence and risk factors. , 1992, The Gerontologist.

[114]  Ove Almkvist,et al.  Early diagnosis of Alzheimer dementia based on clinical and biological factors , 1999, European Archives of Psychiatry and Clinical Neuroscience.

[115]  T. Kaushik,et al.  Development and Validation of a Web-Based Screening Tool for Monitoring Cognitive Status , 2002, The Journal of head trauma rehabilitation.

[116]  Miia Kivipelto,et al.  Introduction: Mild cognitive impairment: beyond controversies, towards a consensus , 2004 .

[117]  E. Tangalos,et al.  CME Practice parameter: , 2022 .

[118]  Brian Mittman,et al.  Guidelines for managing Alzheimer's disease: Part II. Treatment. , 2002, American family physician.

[119]  S. Gauthier,et al.  Assessment of Suspected Dementia , 2001, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[120]  O. Gureje,et al.  Informant reports of changes in personality predict dementia in a population-based study of elderly african americans and yoruba. , 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[121]  J. Karlawish,et al.  Diagnostic Evaluation of Elderly Patients with Mild Memory Problems , 2004, Annals of Internal Medicine.

[122]  D R Wekstein,et al.  Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. Findings from the Nun Study. , 1996, JAMA.

[123]  Alex Kiss,et al.  Neuropsychological tests accurately predict incident Alzheimer disease after 5 and 10 years , 2005, Neurology.

[124]  John C Morris,et al.  Mild cognitive impairment is early-stage Alzheimer disease: time to revise diagnostic criteria. , 2006, Archives of neurology.

[125]  C. Patterson,et al.  The Recognition, Assessment and Management of Dementing Disorders: Conclusions from the Canadian Consensus Conference on Dementia , 1999, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[126]  D. Bennett,et al.  Mild cognitive impairment: is it Alzheimer's disease or not? , 2005, Journal of Alzheimer's disease : JAD.

[127]  D. Spencer,et al.  Practice parameter: Temporal lobe and localized neocortical resections for epilepsy: Report of the Quality Standards Subcommittee of the American Academy of Neurology, in Association with the American Epilepsy Society and the American Association of Neurological Surgeons , 2003, Neurology.

[128]  R. Holloway Early Identification of Alzheimer's Disease and Related Dementias , 1998, Neurology.

[129]  Helena Chmura Kraemer,et al.  Evaluating Medical Tests: Objective and Quantitative Guidelines , 1992 .